High flow nasal cannula Market 2024 - By Size, Segmentation, Application, Outlook And Opportunities Analysis By 2033

The high flow nasal cannula market size has grown rapidly in recent years. It will grow from $5.03 billion in 2023 to $5.61 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising disposable income, changing lifestyle trends, globalization and trade, home renovation and construction activities, e-commerce growth.

The high flow nasal cannula market size is expected to see rapid growth in the next few years. It will grow to $8.23 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to sustainable and eco-friendly products, changing demographics, smart textiles integration, interior design trends, health and wellness textiles. Major trends in the forecast period include smart home integration, sustainable materials and practices, customization and personalization, innovative textile technologies, digital retail experiences.

Market Overview -
High-flow nasal cannula (HFNC) is a medical device used to deliver a high flow of heated and humidified oxygen-enriched air to patients with respiratory conditions. It consists of a lightweight tube connected to a machine that regulates the flow of air and oxygen. The cannula, which is placed in the patient's nostrils, delivers a continuous stream of warm and moistened air at a higher flow rate than traditional oxygen therapy methods.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13454&type=smp

Surging Demand for High-Flow Nasal Cannulas Amidst Rising Asthma and COPD Cases
The rise in asthma and COPD incidence is expected to propel the growth of the high-flow nasal cannula market going forward. Asthma is a disorder in which the airways in the lungs constrict and swell, and excess mucus is produced. COPD, or chronic obstructive pulmonary disease, refers to a set of lung illnesses that make breathing difficult and worsen over time. High-flow nasal cannula has the potential to increase PO2 while minimizing HR and RR and acts as a viable treatment option for individuals suffering from severe bronchial Asthma worsened by respiratory failure. For instance, in April 2023, according to Asthma + Lung UK, a UK-based non-profit organization defending the freedom to breathe, between 2021 and 2022, hospital admissions for children with Asthma surged by 149 percent in England and Wales. Overall, 19,506 children were hospitalised with asthma symptoms between 2020 and 2021, compared with 7,850 between 2020 and 2021. Therefore, the rise in Asthma and COPD incidence is driving the high-flow nasal cannula market.

Competitive Landscape -
Major companies operating in the high flow nasal cannula market report are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., Teijin Pharma Limited, ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Masimo Corporation, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, Sterimed Group, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited.

Innovative Nasal High-Flow Therapy Providing Respiratory Support For Patients With COVID-19 And Other Respiratory Conditions
Major companies operating in the high-flow nasal cannula market are focusing on advanced products like the SoftFlow High-Flow Nasal Cannula to provide their existing consumers. The softFlow High-Flow Nasal Cannula is a breathing assistance device that uses a nasal cannula to give warm, humidified, oxygen-enriched oxygen to patients. For instance, in February 2021, Masimo Corporation, a US-based manufacturer of medical technology, launched the SoftFlow High-Flow Nasal Cannula Therapy. The innovative integrated airflow generator of the soft flow technology and water reservoir attachment enable continued HFNC treatment of recovering COVID-19 patients in the home and other care settings, eliminating the need for a separate source. The technology, which is offered on the softFlow 50, provides high-flow respiratory assistance to adult patients via a soft nasal cannula by delivering a steady high flow of humidified, warm air or an air/oxygen combination. Additionally, SoftFlow delivers continuous airflow through the nostrils, enabling patients to continue eating, drinking, and speaking, which is challenging with mask-based types of respiratory support.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/high-flow-nasal-cannula-global-market-report

Key Segments -
The high flow nasal cannula market covered in this report is segmented -
1) By Type: Air Or Oxygen Blenders, Nasal Cannulas, Active Humidifier, Single Heated Tube, Other Types
2) By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Other Applications
3) By Sales Channel: Direct Channel, Distribution Channel
4) By End-User: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.